Sandra A Mitchell

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc A thematic analysis of theoretical models for translational science in nursing: mapping the field
    Sandra A Mitchell
    National Institutes of Health, Clinical Center, Bethesda, MD, USA
    Nurs Outlook 58:287-300. 2010
  2. pmc Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
    S A Mitchell
    Nursing Research, Clinical Center, National Institutes of Health, Bethesda, MD 20852, USA
    Bone Marrow Transplant 45:762-9. 2010
  3. pmc A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change
    Sandra A Mitchell
    Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 17:1619-29. 2011
  4. ncbi request reprint Cancer-related fatigue: the evidence base for assessment and management
    Sandra A Mitchell
    National Institutes of Health, Clinical Center, Bethesda, Maryland 20892, USA
    Cancer J 12:374-87. 2006
  5. doi request reprint Cancer-related fatigue: state of the science
    Sandra A Mitchell
    National Institutes of Health, Clinical Center, 10 Center Drive, Bethesda, MD 20852, USA
    PM R 2:364-83. 2010
  6. ncbi request reprint Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment
    Sandra A Mitchell
    National Institutes of Health, Bethesda, MD, USA
    Clin J Oncol Nurs 11:99-113. 2007
  7. pmc National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis
    Kristin Baird
    Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 19:632-9. 2013
  8. pmc Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation
    Brian A Harris
    Pain and Palliative Care Service, National Institutes of Health Clinical Center, National Cancer Institute, Bethesda, Maryland 20892, USA
    J Support Oncol 8:119-25. 2010
  9. pmc Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol
    Margaret F Bevans
    National Institutes of Health Clinical Center, Bethesda, MD, USA
    Health Qual Life Outcomes 9:24. 2011
  10. doi request reprint Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease
    Jane M Fall-Dickson
    National Institute of Nursing Research, Bethesda, MD, USA
    Biol Blood Marrow Transplant 16:948-56. 2010

Detail Information

Publications20

  1. pmc A thematic analysis of theoretical models for translational science in nursing: mapping the field
    Sandra A Mitchell
    National Institutes of Health, Clinical Center, Bethesda, MD, USA
    Nurs Outlook 58:287-300. 2010
    ..A flexible theoretical stance is essential to simultaneously develop new knowledge and accelerate the translation of that knowledge into practice behaviors and programs of care that support optimal patient outcomes...
  2. pmc Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
    S A Mitchell
    Nursing Research, Clinical Center, National Institutes of Health, Bethesda, MD 20852, USA
    Bone Marrow Transplant 45:762-9. 2010
    ..004). Results suggest two possible mechanisms underlying impaired functional performance in survivors with cGVHD and underscore the importance of testing interventions to enhance functional capacity and reduce symptom bother...
  3. pmc A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change
    Sandra A Mitchell
    Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 17:1619-29. 2011
    ..Research is needed to evaluate inter- and intrarater reliability in larger samples, and to evaluate these response criteria as predictors of outcomes in clinical trials...
  4. ncbi request reprint Cancer-related fatigue: the evidence base for assessment and management
    Sandra A Mitchell
    National Institutes of Health, Clinical Center, Bethesda, Maryland 20892, USA
    Cancer J 12:374-87. 2006
    ..Cancer-related fatigue contributes to negative outcomes relative to psychosocial and symptom distress, functional status, and quality of life, and yet it is often underdiagnosed and management is frequently suboptimal...
  5. doi request reprint Cancer-related fatigue: state of the science
    Sandra A Mitchell
    National Institutes of Health, Clinical Center, 10 Center Drive, Bethesda, MD 20852, USA
    PM R 2:364-83. 2010
    ....
  6. ncbi request reprint Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment
    Sandra A Mitchell
    National Institutes of Health, Bethesda, MD, USA
    Clin J Oncol Nurs 11:99-113. 2007
    ..In addition to offering patients and clinicians a tool to facilitate effective management of the distressing symptom, this evidence-based review identifies gaps in knowledge and research opportunities...
  7. pmc National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis
    Kristin Baird
    Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 19:632-9. 2013
    ..In this population of severely affected patients, NIH lung score is the strongest predictor of poor overall survival, both alone and after adjustment for other important factors...
  8. pmc Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation
    Brian A Harris
    Pain and Palliative Care Service, National Institutes of Health Clinical Center, National Cancer Institute, Bethesda, Maryland 20892, USA
    J Support Oncol 8:119-25. 2010
    ..Research is needed to identify factors that diminish Sp-WB and to test interventions designed to strengthen this coping resource in patients experiencing the late effects of treatment...
  9. pmc Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol
    Margaret F Bevans
    National Institutes of Health Clinical Center, Bethesda, MD, USA
    Health Qual Life Outcomes 9:24. 2011
    ....
  10. doi request reprint Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease
    Jane M Fall-Dickson
    National Institute of Nursing Research, Bethesda, MD, USA
    Biol Blood Marrow Transplant 16:948-56. 2010
    ..The positive associations between IL-6 and oral cGVHD severity and erythema, as well as the positive trend with oral ulceration, warrant further exploration of this cytokine as a potential biomarker of active oral cGVHD...
  11. pmc Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation
    Matin M Imanguli
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 16:1362-9. 2010
    ..Formal evaluation of salivary function using standardized criteria is needed, and this could be incorporated as an outcome measure in clinical trials of cGVHD...
  12. pmc Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease
    Kathryn J Martires
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Blood 118:4250-7. 2011
    ..Widespread skin involvement is associated with significant functional impairment, distressing symptoms, and diminished survival. This trial is registered at http://www.clinicaltrials.gov as NCT00331968...
  13. pmc Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies
    Robert Quan Le
    Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 20892 1202, USA
    Biol Blood Marrow Transplant 16:1162-70. 2010
    ..These results show that 5 or more years after T cell-depleted HSCT for hematologic malignancy most individuals survive disease free with an excellent performance status, preserved physical and psychological health, and excellent HRQL...
  14. pmc The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)
    Margaret F Bevans
    National Institutes of Health, Clinical Center, 10 Center Drive, Room 2BO1, MSC 1151, Bethesda, MD 20892, USA
    Support Care Cancer 16:1243-54. 2008
    ..Despite advances in allogeneic hematopoietic stem cell transplantation (HSCT), post-transplant complications are common, and patients' symptom experience has not been well documented...
  15. ncbi request reprint Acute renal failure: early detection and prompt intervention can improve outcomes
    Stacie Coburn
    Stem Cell Transplant Program, Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA
    Am J Nurs 102:6-12; quiz 49-52. 2002
  16. pmc Implementing evidence-based practice: effectiveness of a structured multifaceted mentorship programme
    Gwenyth R Wallen
    Nursing Research and Translational Science National Institutes of Health, Clinical Center, Bethesda, Maryland, USA
    J Adv Nurs 66:2761-71. 2010
    ..This paper is a report of the effectiveness of a structured multifaceted mentorship programme designed to implement evidence-based practice in a clinical research intensive environment...
  17. ncbi request reprint The cancer survivor's prescription for living
    Pamela J Haylock
    University of Texas Medical Branch, Galveston, USA
    Am J Nurs 107:58-70; quiz 71. 2007
  18. ncbi request reprint Evidence-based guidelines for the management of neutropenia following outpatient hematopoietic stem cell transplantation
    Fran West
    Cancer Center Methodist University Hospital, Memphis, TN, USA
    Clin J Oncol Nurs 8:601-13. 2004
    ..Patient and family education, psychosocial support, and coordination of care are key nursing responsibilities...
  19. ncbi request reprint Modifying cancer-related fatigue by optimizing sleep quality
    Ann Malone Berger
    University of Nebraska Medical Center, Omaha, NE 68198 5330, USA
    J Natl Compr Canc Netw 6:3-13. 2008
    ....
  20. ncbi request reprint Cognitive impairment in patients with brain tumors: assessment and intervention in the clinic setting
    Sherry W Fox
    School of Nursing, University of Virginia, Charlottesville, USA
    Clin J Oncol Nurs 10:169-76. 2006
    ..The use of cognitive screening to guide timely intervention, such as referral to a neuropsychologist and the provision of anticipatory guidance to people with brain tumors and their families, is discussed...